$0.79 EPS Expected for Cabot Corp (CBT) This Quarter

Equities analysts expect Cabot Corp (NYSE:CBT) to post $0.79 earnings per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Cabot’s earnings, with the highest EPS estimate coming in at $0.95 and the lowest estimate coming in at $0.73. Cabot reported earnings of $0.84 per share during the same quarter last year, which suggests a negative year over year growth rate of 6%. The business is expected to report its next quarterly earnings report on Wednesday, February 7th.

On average, analysts expect that Cabot will report full-year earnings of $3.79 per share for the current year, with EPS estimates ranging from $3.70 to $3.90. For the next fiscal year, analysts forecast that the firm will post earnings of $4.21 per share, with EPS estimates ranging from $4.05 to $4.40. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Cabot.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share for the quarter, missing the consensus estimate of $0.93 by ($0.02). Cabot had a return on equity of 15.11% and a net margin of 8.87%. The company had revenue of $723.00 million for the quarter, compared to analyst estimates of $683.30 million. During the same period in the prior year, the business posted $1.00 earnings per share. Cabot’s revenue for the quarter was up 16.8% on a year-over-year basis.

A number of equities research analysts have recently commented on CBT shares. Loop Capital started coverage on Cabot in a research report on Thursday, September 28th. They set a “hold” rating and a $59.00 target price on the stock. KeyCorp restated a “hold” rating on shares of Cabot in a research report on Wednesday, November 1st. Jefferies Group restated a “buy” rating and set a $74.00 target price on shares of Cabot in a research report on Friday, November 3rd. Zacks Investment Research cut Cabot from a “buy” rating to a “hold” rating in a research report on Tuesday, November 7th. Finally, SunTrust Banks upgraded Cabot from a “hold” rating to a “buy” rating in a research report on Tuesday, December 19th. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Cabot currently has an average rating of “Buy” and a consensus target price of $64.43.

Cabot (NYSE:CBT) traded up $0.03 during trading hours on Friday, hitting $62.88. The stock had a trading volume of 149,100 shares, compared to its average volume of 205,200. Cabot has a 52-week low of $50.21 and a 52-week high of $64.66. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.70 and a quick ratio of 1.17. The firm has a market cap of $3,893.53, a PE ratio of 16.50, a PEG ratio of 1.66 and a beta of 1.11.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 8th. Stockholders of record on Friday, November 24th were given a dividend of $0.315 per share. This represents a $1.26 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date was Wednesday, November 22nd. Cabot’s dividend payout ratio (DPR) is presently 33.07%.

A number of institutional investors have recently modified their holdings of the stock. Parametric Portfolio Associates LLC lifted its stake in Cabot by 1.3% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 386,033 shares of the specialty chemicals company’s stock valued at $21,541,000 after buying an additional 4,808 shares in the last quarter. AXA lifted its stake in Cabot by 21.5% in the 3rd quarter. AXA now owns 172,170 shares of the specialty chemicals company’s stock valued at $9,607,000 after buying an additional 30,450 shares in the last quarter. Public Employees Retirement System of Ohio lifted its stake in Cabot by 51.9% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 93,931 shares of the specialty chemicals company’s stock valued at $5,241,000 after buying an additional 32,110 shares in the last quarter. FrontFour Capital Group LLC purchased a new position in Cabot in the 3rd quarter valued at about $824,000. Finally, California Public Employees Retirement System lifted its stake in Cabot by 4.4% in the 3rd quarter. California Public Employees Retirement System now owns 129,381 shares of the specialty chemicals company’s stock valued at $7,219,000 after buying an additional 5,481 shares in the last quarter. 84.83% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “$0.79 EPS Expected for Cabot Corp (CBT) This Quarter” was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2018/01/05/0-79-eps-expected-for-cabot-corp-cbt-this-quarter.html.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Get a free copy of the Zacks research report on Cabot (CBT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply